Toggle navigation
Home
Search
Services
Blog
Contact
About
Specific DNA Damage and Neoplastic Transformation
Von Hofe, Eric H.
Hybridon, Inc., Cambridge, MA, United States
Search grants from Eric Von Hofe
Search grants from Hybridon, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Regulation of Protein N-Glycosylation in the CNS
Couples Intervention for Cardiac Risk Reduction
Immediate Early Genes in Astrocyte Development
Functions of Biogenic Amine Transporters
Function and Control of OCT-2 Expression in T Lineage Cells
Recently added grants:
Identifying molecular markers that predict relapse after therapy discontinuation inchronic myeloid leukemia.
Insulin Resistance, Biomarkers of Brain Function, and Intermittent Calorie Restriction
Clinical Efficacy of Focused Ultrasound (MR-HIFU) Treatment of Symptomatic Osteoid Osteoma in Pediatrics
Effects of HFE H63D on Brain Mn Accumulation and Neurotoxicity
mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
James A. Shannon Director's Award (R55)
Project #
7R55CA051103-02
Application #
3509570
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1993-07-15
Project End
1994-06-30
Budget Start
1993-07-15
Budget End
1994-06-30
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
Hybridon, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Related projects
NIH 1991
R55 CA
Specific DNA Damage & Neoplastic Transformation
Von Hofe, Eric H. / University of Massachusetts Medical School Worcester
NIH 1991
R55 CA
Specific DNA Damage and Neoplastic Transformation
Von Hofe, Eric H. / Hybridon, Inc.
Comments
Be the first to comment on Eric Von Hofe's grant